Sonepcizumab (LT 1009) 是一种完全人源化的抗S1P单克隆抗体。Sonepcizumab 具有用于转移性肾细胞癌 (mRCC) 研究的潜力。
| 生物活性 | Sonepcizumab (LT 1009) is a fully humanized anti-S1Pmonoclonal antibody. Sonepcizumab has the potential for the research of metastatic renal cell carcinoma (mRCC)[1]. |
| CAS 号 | |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
m.cnreagent.com